Myotonic Dystrophy 1 (DMPK) genetic testing (repeat expansion)-994

Test info

  
Myotonic Dystrophy 1 (DMPK) genetic testing (repeat expansion)
  
994
  
LAB994
  
MSO
  
DMPK repeat expansion
  

Type 1 myotonic dystrophy results from a mutation in the DMPK gene known as a trinucleotide repeat expansion. This mutation increases in the size of the repeated CTG segment in the DMPK gene. People with type 1 myotonic dystrophy have from 50 to 5,000 CTG repeats in most cells. The number of repeats may be even greater in certain types of cells, such as muscle cells.

  

False positive or false negative results may occur for reasons that include insufficient information available about rare genetic variants, allele dropout, blood transfusions, bone marrow transplantation, somatic or tissue-specific mosaicism, or mislabeled samples. Maximum reportable size of repeat expansion testing: ATN1: 110 repeats; ATXN1: 150 repeats (repeats greater than 40 in the ATXN1 gene cannot be assessed for CAT interruptions); ATXN2: 150 repeats; ATXN3: 120 repeats; ATXN7: 125 repeats; ATXN8/ATXN8OS: 150 repeats; ATXN10: 70 repeats; C9orf72: 65 repeats; CACNA1A: 145 repeats; CNBP: 373 base pairs (approximately 75 repeats); DMPK: 150 repeats; FXN: 1300 repeats; HTT: 100 repeats; JPH3: 100 repeats; NOP56: 65 repeats; PPP2R2B: 150 repeats; TBP: 120 repeats. Repeat sizes greater than the maximum reportable range are reported as greater than the largest reportable repeat size. This test was developed and its performance characteristics determined by Labcorp. It has not been cleared or approved by the Food and Drug Administration.

Specimen

  
EDTA whole blood
  
  
4.0 mL
  
2.0 mL
  

Immediately after collection, mix tube thoroughly by gentle inversion, 8 - 10 times, to prevent clotting

  

Lavender (EDTA), 4mL

  

Molecular Medicare Billing Request

Hospital clients submitting a request for this assay on an outpatient with Medicare should complete and submit a Molecular Medicare billing request form to notify us of the need for Allina Health Laboratory to bill insurance.

  

Ambient (preferred) - 14 days

Refrigerated  – 30 days

Frozen – NO

  
  • Frozen specimens
  • Hemolyzed specimens

Performance

  
Medical Neurogenetic (MOL229) via LabCorp (620084): R-NX
  
Mo - Fr
  
2 - 4 weeks
  

Repeat-Primed PCR and fragment length analysis to identify number of nucleotide repeats.

Clinical and Interpretive info

  

# of repeats

  

Maximum reportable sizing: 150 repeats

Billing

  
This test may require preauthorization from the insurance provider. Check the payer guidelines and, if needed, obtain the pre-authorization prior to sample collection.
  
81234
  
Result UNLOINC
  

Medical necessity

Hospital clients submitting a request for this assay on an outpatient with Medicare should complete and submit a Molecular Medicare billing request form to notify us of the need for Allina Health Laboratory to bill insurance.

Molecular Medicare Billing Request

Tracking

  
05/24/2019
  
09/03/2024
  
12/27/2023